Stockreport

Zenas BioPharma, Inc. Investigated by the Portnoy Law Firm

Zenas BioPharma, Inc.  (ZBIO) 
PDF LOS ANGELES, April 17, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Zenas BioPharma, Inc., (“Zenas" or the "Company") (NASDAQ: ZBIO) investors that the firm h [Read more]